Robotics is the Next Wave of Automation Systems for Stadiums and Arenas

September 23, 2062, is still forty years away, but it’s an important historical date. One hundred years before, on September 23, 1962, the Jetsons premiered on ABC television. The Jetsons imagined a world one hundred years into the future, a time with flying cars and robot servants. How closely the future will resemble the ideas of the early 60s is still a wait and see, but some of the innovations that existed in the imaginations of Jetsons writers are taking place today.

Sports arenas and venues are not unfamiliar with using automation systems technology to reduce concession lines and get fans back in their seats faster. But are robotic servers the next evolutionary step? TechFoundry LLC Consultant Tod Caflisch says the staffing shortages and the need to cut costs seen in retail and other consumer-facing industries affect sports and entertainment, too, leading to the exploration of robotics and other automated systems to reduce the burden.

“There’s a platform called TendedBar that’s already been successfully used in a number of arenas and events,” Caflisch says. “Basically, it’s a contactless point of sale device for cocktails and mixed drinks.” An App utilizing facial recognition and biometrics verifies age and allows for order and payment. There is also an automated bartender robot called BRILLO, who can mix drinks and make small talk.

Another example of robot automation transforming the restaurant industry that could also make an impact in sports venues is Flippy. Flippy is a robot hamburger flipper and the world’s first autonomous robotic kitchen assistant. Developed by Miso Robotics, an AI and robotics startup focused on the restaurant industry, Flippy is a machine-learning robot that helps chefs with food prep, grilling, frying, and final assembly in commercial kitchens. Flippy 2 launched earlier this summer, and Sippy, the world’s first POS-integrated beverage dispenser and sealer, is poised to launch before the end of 2022.

But how close is the world coming to an actual house-optimized robot, like Rosie the Robot from the Jetsons? Closer than one might imagine. Elon Musk is nearing completion of a prototype for the first functioning humanoid robot, which could debut as early as the end of this coming September. No matter the form these innovations take, they are starting to pop up around stadiums. Caflisch says, “Check it out. The next time you go out to the arena or stadium for a game or a concert, and see, because I think you’re going to be catching more of that.”

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More